VK

Vimal Kavuru

North America, New York, United States, New York

Description

Vimal Kavuru is Chief Executive Officer at Rising Pharmaceuticals. He attended Long Island University.

Investor Profile

Vimal Kavuru has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in India.
  • Strong thematic focus on Credit, FinTech, Health Care.

Stage Focus

  • Seed (100%)

Country Focus

  • India (100%)

Industry Focus

  • Credit
  • Fintech
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Vimal Kavuru frequently co-invest with?

Loric Ventures
Europe, Berlin, Germany, Berlin
Co-Investments: 1
GP
North America, Missouri, United States, Jefferson City
Co-Investments: 1
Nordstar
Europe, England, United Kingdom, London
Co-Investments: 1
Leonis Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 1
MyAsia VC
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Kube VC
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
FV
North America, Florida, United States, West Palm Beach
Co-Investments: 1
Leblon Capital
Europe, Bayern, Germany, Munich
Co-Investments: 1
10x Founders
Europe, Bayern, Germany, Munich
Co-Investments: 1
Goodwater Capital
North America, California, United States, Burlingame
Co-Investments: 1

Which angels does Vimal Kavuru often collaborate with?

MK
Asia, Singapore
Shared Deals: 1
OJ
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Vimal Kavuru?

SaveIN

New Delhi, Delhi, India

SaveIN helps people discover healthcare practices near them and enables them to split their medical bills into monthly installments.

CreditFinTechHealth Care
SeedApr 19, 2022
Amount Raised: $3,924,357